| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 178.68B | 121.00B | 106.12B | 158.81B | 318.98B |
| Gross Profit | 178.68B | 121.00B | 123.32B | 104.86B | 316.11B |
| EBITDA | 40.54B | 26.91B | 19.85B | 12.65B | 16.45B |
| Net Income | 27.06B | 8.43B | 5.37B | 4.30B | 7.51B |
Balance Sheet | |||||
| Total Assets | 1.99T | 1.73T | 1.51T | 1.41T | 1.38T |
| Cash, Cash Equivalents and Short-Term Investments | 62.01B | 44.39B | 42.55B | 308.46B | 293.80B |
| Total Debt | 201.66B | 82.12B | 101.43B | 117.05B | 95.17B |
| Total Liabilities | 1.84T | 1.61T | 1.38T | 1.31T | 1.27T |
| Stockholders Equity | 95.15B | 87.07B | 78.99B | 75.51B | 88.07B |
Cash Flow | |||||
| Free Cash Flow | 151.32B | 116.24B | 127.67B | 88.72B | 94.48B |
| Operating Cash Flow | 156.75B | 125.95B | 134.60B | 95.02B | 98.63B |
| Investing Cash Flow | -149.61B | -95.63B | -130.95B | -80.30B | -99.62B |
| Financing Cash Flow | 1.65B | -27.91B | 19.79B | -9.76B | 9.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.05T | 4.51 | 31.07% | 3.42% | 17.69% | 126.41% | |
71 Outperform | HK$390.79B | 9.89 | 18.91% | 3.28% | 15.08% | 23.13% | |
70 Outperform | HK$75.91B | 2.48 | 29.19% | 1.81% | 23.64% | 36.32% | |
70 Outperform | HK$905.29B | 17.34 | 15.16% | 2.16% | 5.65% | 30.47% | |
70 Outperform | HK$191.24B | 4.31 | 38.67% | 5.24% | 49.90% | 203.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.14T | 8.07 | 14.77% | 4.25% | 10.20% | 19.74% |